Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
4 Patents
#288 in Salt Lake City, UT
#780 in Utah
#60,737 in US
Prolexys Pharmaceuticals, Inc.
Forward Citations = 30
16 inventors:
Salt Lake City, UT, United States of America
Prolexys Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 100.0
EPO Patents = 1
Forward Citations = 30
Loading Chart...
Loading Chart...
16 inventors (with patents filed for the assignee):
Paul B Robbins (4 out of 5 patents)
Longwu Qi (3 out of 4 patents)
Raj Gopal Venkat (3 out of 3 patents)
4. Sudhir R Sahasrabudhe (3 out of 3 patents)
5. Robert Selliah (3 out of 4 patents)
6. Brent R Stockwell (2 out of 25 patents)
7. Moritz Von Rechenberg (2 out of 11 patents)
8. John M Peltier (2 out of 2 patents)
9. John Jay Boniface (1 out of 6 patents)
10. Michael Pierce (1 out of 2 patents)
11. Robert R Becklin (1 out of 1 patent)
12. Cindy Lou Chepanoske (1 out of 1 patent)
13. Keith Simmon (1 out of 1 patent)
14. Eugene Y Zhen (1 out of 1 patent)
15. Vladimir Kery (1 out of 1 patent)
4 patents:
Company Overview
Prolexys Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases. With a team of experienced scientists and cutting-edge technology, Prolexys is dedicated to advancing the field of drug discovery. The company's research efforts are centered around identifying novel drug targets and developing targeted therapies that have the potential to improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prolexys Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/prolexys-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]